About this release

This is the sixth report on Residential Rehabilitation within the Monitoring and Evaluation Programme led by Public Health Scotland. The report presents information on the number of Alcohol and Drug Partnership (ADP) statutory funded placements into residential rehabilitation, with estimated costs, that were approved between 1 April 2021 and 31 December 2022. Information is provided at a Scotland level, NHS Board and each Alcohol and Drug Partnership. 

Main points

  • In Q3 2022/23, 228 statutory funded placements were approved for residential rehabilitation in Scotland. This is an increase of 99 placements when compared to Q3 2021/22 (n=129), and an increase of 47 placements when compared to Q2 2022/23 (n=181).
  • Of the 228 placements approved in Q3 2022/23, 182 placements were approved by ADPs; 20 placements were approved by Ward 5 Woodland View in NHS Ayrshire and Arran, and 26 placements were approved through the Scottish Government's National Mission Programme. Figure 1 below shows the total number of ADP approved placements, and the yearly average, from 1 April 2021 to 31 December 2022.     
  • The 26 National Mission funded placements include the following services: the Prison to Rehab pathway; Aberlour Mother and Child Recovery House; River Garden Auchincruive and Phoenix Future Harper House, Specialist Family Service Scotland.
  • The total estimated cost for 228 placements was £1,965,532. This cost is made up of £1,493,482 from 182 ADP approved placements, £300,240 for 20 placements to Ward 5 Woodland View, and  £171,810 for ten Prison to Rehab placements, which is included under the National Mission programme.  Cost information has not yet been provided for Aberlour Mother and Child Recovery House; River Garden and Phoenix Future Harper House, Specialist Family Service Scotland.
  • The largest number of ADP approved placements (n=66) since April 2021, occurred in October 2022
  • Information on the characteristics of individuals offered placements was available for the ADP approved placements (n=182), in Q3 2022/23, and this showed:
    • 68% of placements were for males (n=124), and 32% of placements were for females (n=58).
    • 49% (n=89) of the 182 approved placements by ADPs were for people with problematic alcohol use, 38% (n=69) was for people with problematic drug use, and 13% (n=24), was for people with co-dependency.
  • The largest number of approved placements by ADPs was Glasgow City (n=42,23%), followed by West Dunbartonshire ADP (n=21,12%) and then Highland (n=20,11%). Please note that the figure for Highland includes 13 placements for a two-week treatment programme, and 7 placements for a 14-week treatment programme. Caution must be made when comparing data between ADPs.
  • The most common reason for ADPs submitting a nil return during Q3 2022/23 was due to no referrals being received for residential rehabilitation treatment.
  • Overall, between 1 April 2021 and 31 December 2022, 1,119 statutory funded placements (includes ADP approved placements, National Mission funded placements and Ward 5 data) for residential rehabilitation were approved in Scotland. The total estimated cost was £8,624,861.  

Figure 1: Number of ADP Approved Placements in Scotland, 1 April 2021 to 31 December 2022

The specified path, file name, or both are too long. The fully qualified file name must be less than 260 characters, and the directory name must be less than 248 characters.

Background

Residential rehabilitation is a well-established intervention for the treatment of drug and alcohol problems and is recognised as an important option for some people requiring treatment.  As part of the National Mission, the Scottish Government has committed to invest £100M for residential rehabilitation over the next five years.  Since 2021/22, and for the next five years, the Alcohol and Drugs Partnerships in Scotland have been allocated £13.5M, with £5M earmarked to support additional capacity and access Residential Rehabilitation services. 

Further information

The next release of this publication will be 20 June 2023.

General enquiries

If you have an enquiry relating to this publication, please email phs.evaluationteam@phs.scot.

Media enquiries

If you have a media enquiry relating to this publication, please contact the Communications and Engagement team.

Requesting other formats and reporting issues

If you require publications or documents in other formats, please email phs.otherformats@phs.scot.

To report any issues with a publication, please email phs.generalpublications@phs.scot.

Older versions of this publication

Versions of this publication released before 16 March 2020 may be found on the Data and Intelligence, Health Protection Scotland or Improving Health websites.

Last updated: 21 March 2024
Error loading Partial View script (file: ~/Views/MacroPartials/InsertUmbracoFormWithTheme.cshtml)